Literature DB >> 3015220

Biochemical and ultrastructural studies on an Epstein-Barr virus-transformed lymphoid cell line from a Niemann-Pick disease type C patient.

T Levade, A Maret, R Salvayre, N Livni, P Rogalle, L Douste-Blazy.   

Abstract

Human lymphoid cell lines established from normal subjects and from a Niemann-Pick disease type C patient were investigated from a triple point of view of enzymology, metabolism and ultrastructure: Sphingomyelinase activities, isoenzyme electrofocusing profiles and properties of the major enzyme were quite similar in type C and normal lymphoid cell lines. Similarly, no significant difference was observed in non-specific phosphodiesterases hydrolysing bis(methylumbelliferyl)phosphate and bis(methylumbelliferyl)pyrophosphate. The study of the lipid composition of type C cells showed no obvious accumulation of sphingomyelin or other phospholipid, but only a higher amount of glycolipids (mainly GlcCer and GbOse3Cer), as visualized by bidimensional thin-layer chromatography. Ultrastructural studies demonstrated, in type C cells, the presence of an obvious lysosomal storage of amphiphilic lipids quite similar to that observed in tissues of type C patients. These studies, which demonstrate the validity of lymphoid cell lines as an experimental model system for type C disease, agree with the current opinion that an impairment of sphingomyelin catabolism is not the primary defect in type C disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015220     DOI: 10.1016/0005-2760(86)90207-9

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Evidence for both endogenous and exogenous sources of the sphingomyelin storage in lymphoid cell lines from patients with Niemann-Pick disease types A and B.

Authors:  T Levade; R Salvayre; A Maret; L Douste-Blazy
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

2.  Deficiency of niemann-pick type C-1 protein impairs release of human immunodeficiency virus type 1 and results in Gag accumulation in late endosomal/lysosomal compartments.

Authors:  Yuyang Tang; Ihid Carneiro Leao; Ebony M Coleman; Robin Shepard Broughton; James E K Hildreth
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

3.  LAMP2 as a marker of EBV-mediated B lymphocyte transformation in the study of lysosomal storage diseases.

Authors:  A S Mello; M P Goldim; J Mezzalira; C S Garcia; V V Daitx; V V Daitz; C D Castilhos; M S Viegas; O V Vieira; J C Coelho
Journal:  Mol Cell Biochem       Date:  2013-09-26       Impact factor: 3.396

4.  Effect of one year of cryopreservation on the activity of lysosomal hydrolases from EBV-transformed lymphocytes.

Authors:  A S de Mello; F B Mendes; K Michelin-Tireli; M V Camelier; J C Coelho
Journal:  J Biomed Biotechnol       Date:  2011-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.